Endocrine and metabolic late effects following cancer treatment: challenges and controversies

Endocr Connect. 2022 Aug 11;11(9):e220261. doi: 10.1530/EC-22-0261. Print 2022 Sep 1.

Authors

Judith Gebauer¹, Claire E Higham²

Affiliations

¹ Department of Internal Medicine I, University Hospital Schleswig-Holstein, Luebeck, Germany.
² Department of Endocrinology, Christie Hospital NHS Foundation Trust, University of Manchester, and Manchester Academic Health Science Centre, Manchester, UK.

No abstract available

Publication types

Editorial